Press release content from Accesswire. The AP news staff was not involved in its creation.
Ximen Announces Term Sheet for US $5M to Fund Development of Kenville Gold Mine
February 10, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Ximen Mining Corp. (TSXV:XIM)(FRA:1XMA)(OTCQB:XXMMF) (the “Company” or “Ximen”) is pleased to announce that it has signed an indicative term sheet with an arm’s-length Swiss-based metals trading firm (the “Lender”) to provide US$5.0 million of financing in the form of a secured gold loan (the “Loan”), for the planned development of a 1200 meter decline and extraction of a 10,000-tonne bulk sample at the Company’s Kenville Gold Mine property.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Capitalab named OTC Infrastructure Service of the Year
February 10, 2021 GMT
BGC Partners, Inc. logo. (PRNewsFoto/BGC Partners, Inc.) (PRNewsFoto/)
LONDON, Feb. 10, 2021 /PRNewswire/ Capitalab, a division of BGC Brokers LP, an entity within the BGC Partners, Inc. (NASDAQ: BGCP) group of companies, has been named the winner of the 2021 OTC Infrastructure Service of the Year award by Risk.net, the financial industry’s leading publication for in-depth news and analysis on risk management, derivatives and regulation.
In 2020, Capitalab expanded many of its key multilateral optimisation offerings, including the addition of a discount rate labelling service to its interest rate option compression product, the inclusion of LCH SwapAgent-settled swaptions and cross currency basis swaps within its Rates Initial Margin Optimisation service, and the launch of its FX Forward compression and optim
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biophytis Announces Trading Resumption of its Ordinary Shares and Share Warrants on Euronext Growth
BIOPHYTIS SAFebruary 10, 2021 GMT
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces the resumption of trading of its ordinary shares and share warrants on the regulated market of Euronext Growth as from 4 p.m. CET, subject to timing on Nasdaq capital Market.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
February 10, 2021 GMT
SOMERSET, N.J. (BUSINESS WIRE) Feb 10, 2021
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), priced a private offering (the “Private Offering”) of $550 million in aggregate principal amount of 3.125% senior unsecured notes due 2029 (the “Notes”) at par, which represents an increase of $75 million from the offering size previously announced.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Accenture Launches New Business Group with VMware to Help Organizations Move to the Cloud Faster
February 10, 2021 GMT
Accenture and VMWare partner to launch a new business group (Photo: Business Wire)
NEW YORK & PALO ALTO, Calif. (BUSINESS WIRE) Feb 10, 2021
Accenture (NYSE: ACN) and VMware (NYSE: VMW) today announced an expanded partnership and the launch of a dedicated business group that will help organizations adopt a ‘cloud first’ strategy accelerating migration to the cloud, building modern apps more rapidly, and using the cloud as a foundation for innovation and new business models, ultimately realizing greater value.